selegiline has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, CS; Mao, W; Qin, F; Shite, J | 1 |
| Dong, E; Kawai, H; Liang, CS; Shite, J; Stevens, SY | 1 |
2 other study(ies) available for selegiline and Cardiac Failure
| Article | Year |
|---|---|
Selegiline attenuates cardiac oxidative stress and apoptosis in heart failure: association with improvement of cardiac function.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Chronic Disease; Deoxyguanosine; Heart Failure; Heart Ventricles; Hemodynamics; Immunohistochemistry; Mitochondria, Heart; Neuroprotective Agents; Norepinephrine; Oxidative Stress; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rabbits; Selegiline | 2003 |
Selegiline improves cardiac sympathetic terminal function and beta-adrenergic responsiveness in heart failure.
Topics: Analysis of Variance; Animals; Baroreflex; Binding Sites; Cardiac Pacing, Artificial; Disease Models, Animal; Echocardiography; Heart; Heart Failure; Immunohistochemistry; Isoproterenol; Neuroprotective Agents; Norepinephrine; Rabbits; Receptors, Adrenergic, beta; Selegiline; Sympathetic Nervous System; Sympatholytics | 2000 |